Skip to main content
EXAGEN INC. logo

EXAGEN INC. — Investor Relations & Filings

Ticker · XGN ISIN · US30068X1037 LEI · 549300JV2CYDOME5OO17 US Human health and social work activities
Open in API
Filings indexed 397 across all filing types
Latest filing 2015-02-17 Capital/Financing Update
Country US United States of America
Listing US XGN

About EXAGEN INC.

https://exagen.com/

Exagen Inc. is a commercial-stage life sciences company focused on transforming the care continuum for patients with complex autoimmune diseases. Operating as a rheumatology specialty laboratory, the company develops and provides advanced testing solutions for the diagnosis, prognosis, and monitoring of these conditions. Its core offering is the AVISE® testing portfolio, which leverages proprietary biomarker technology to provide physicians with critical insights for timely and accurate differential diagnosis. These tools are designed to empower healthcare providers, particularly rheumatologists, in managing debilitating chronic diseases such as lupus and rheumatoid arthritis, ultimately aiming to improve patient outcomes.

Recent filings

Filing Released Lang Actions
AMENDMENT NO. 3 TO FORM S-1
Capital/Financing Update Classification · 95% confidence The document is an Amendment No. 3 to Form S-1 Registration Statement filed with the SEC, which is a registration statement for an initial public offering (IPO). It includes detailed information about the company, the offering, risk factors, use of proceeds, capitalization, management, and financial data. Form S-1 is a regulatory filing used to register securities with the SEC prior to an IPO. This type of document is not an annual report, earnings release, or any other financial report but a capital markets registration statement. According to the filing definitions, updates on company fundraising or capital structure changes fall under Capital/Financing Update (CAP). Since this is a registration statement for an IPO, it is best classified as a Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains the full registration statement, not just an announcement or a certification, so it is not RPA or RNS. Therefore, the correct classification is CAP with high confidence.
2015-02-17 English
AMENDMENT NO. 2 TO FORM S-1
Capital/Financing Update Classification · 100% confidence The document is an Amendment No. 2 to Form S-1 Registration Statement filed with the SEC, dated November 7, 2014, for Exagen Diagnostics, Inc. It is a registration statement under the Securities Act of 1933, used for initial public offerings (IPOs) or other securities offerings. The text includes detailed information about the offering, company overview, risk factors, use of proceeds, capitalization, management, and financial data. This type of filing is a capital markets document related to fundraising and securities registration, not a financial report, earnings release, or management discussion. Therefore, it fits the category of Capital/Financing Update (CAP).
2014-11-07 English
AMENDMENT NO. 1 TO FORM S-1
Regulatory Filings Classification · 100% confidence The document is an Amendment No. 1 to Form S-1 Registration Statement filed with the SEC by Exagen Diagnostics, Inc. It is a registration statement under the Securities Act of 1933 for an initial public offering (IPO) of common stock. The text includes detailed information typical of a prospectus, such as risk factors, use of proceeds, capitalization, dilution, management discussion and analysis, business overview, executive compensation, principal stockholders, and underwriting details. This type of filing is a registration statement for securities offering, which is not covered by the other specific categories like Annual Report, Earnings Release, or Capital/Financing Update. The S-1 registration statement is a regulatory filing related to securities offering and is best classified under Regulatory Filings (RNS) as it does not fit the other categories and is a general regulatory announcement filed with the SEC.
2014-10-09 English
FORM S-1
Capital/Financing Update Classification · 100% confidence The document is a Form S-1 Registration Statement filed with the SEC, dated September 19, 2014, for Exagen Diagnostics, Inc. It is a preliminary prospectus for an initial public offering (IPO) of common stock. The text includes detailed company information, risk factors, use of proceeds, capitalization, dilution, financial data, management discussion, business overview, executive compensation, principal stockholders, and underwriting details. This type of filing is a registration statement for securities offerings, which is a capital markets document related to fundraising and issuance of new shares. It is not an annual report, earnings release, or any other financial report type. The appropriate classification for this document is a Capital/Financing Update (CAP), as it relates to company fundraising and securities registration.
2014-09-19 English
Regulatory Filings 2014
Regulatory Filings Classification · 100% confidence The document is a Form S-1 Registration Statement filed confidentially with the SEC, dated August 4, 2014, for Exagen Diagnostics, Inc. It is a preliminary prospectus for an initial public offering (IPO) of common stock. The text includes detailed information about the company, its business, risk factors, management, financial data, and underwriting details. This type of filing is a registration statement for securities offering under the Securities Act of 1933, which is distinct from the other categories listed. The closest relevant category in the provided list is 'Regulatory Filings (RNS)' as it covers general regulatory announcements and filings that do not fit other specific categories. The document is not an Annual Report, Earnings Release, or any other financial report but a registration statement for a capital raising event. Therefore, the appropriate classification is Regulatory Filings (RNS).
2014-08-04 English
Regulatory Filings 2014
Regulatory Filings
2014-07-21 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.